| Literature DB >> 32368646 |
Yinager Workineh1, Ayele Semachew2, Emiru Ayalew2, Worku Animaw2, Mulat Tirfie3, Minychil Birhanu1.
Abstract
BACKGROUND: Birth asphyxia leads to about 4 million neonatal deaths every year around the globe. But, the pooled prevalence of asphyxia was not yet collated in East and Central African countries. Hence, this systematic review and meta-analysis aimed to determine the pooled prevalence of perinatal asphyxia in Central and East Africa.Entities:
Keywords: Asphyxia; Clinical research; Critical care; East and Central Africa; Intensive care medicine; Pediatrics; Perinatal; Pooled prevalence; Public health
Year: 2020 PMID: 32368646 PMCID: PMC7184262 DOI: 10.1016/j.heliyon.2020.e03793
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Flowchart to a selection of studies for a systematic review and meta-analysis of the prevalence of perinatal asphyxia in east and central Africa, 2019.
Descriptive summary of 13 studies included in the meta-analysis of the prevalence perinatal asphyxia in East and Central Africa.
| Authors name | Publication Year | Country | Region | Design | Measuring tools | Response rate (%) | Sample size | Prevalence (%) | Quality of study |
|---|---|---|---|---|---|---|---|---|---|
| Sepeku A et al | 2011 | Tanzania | East Africa | cross-sectional | Apgar score <7 | 100.0 | 190 | 21.1 | 7 |
| Belachew et al | 2017 | Ethiopia | East Africa | cross-sectional | Apgar score <7 | 99.0 | 368 | 12.5 | 6 |
| Ibrahim A et al | 2017 | Ethiopia | East Africa | cross-sectional | Apgar score <7 | 100.0 | 9738 | 3.1 | 6 |
| Kibai K et al | 2017 | Kenya | East Africa | cross-sectional | Apgar score <7 | 100.0 | 422 | 29.1 | 7 |
| Demisse G et al | 2017 | Ethiopia | East Africa | cross-sectional | Apgar score <6 | 100.0 | 769 | 12.5 | 8 |
| Gebreheat G et al | 2018 | Ethiopia | East Africa | cross-sectional | Apgar score <7 | 99.7 | 421 | 22.1 | 8 |
| Asfere W et al | 2018 | Ethiopia | East Africa | cross-sectional | Apgar score <7 | 100.0 | 154 | 29.9 | 7 |
| Gichogo M et al | 2018 | Kenya | East Africa | cross-sectional | Apgar score <7 | 100.0 | 237 | 5.1 | 8 |
| Abkika BM et al | 2018 | Chad | Central Africa | cross-sectional | Apgar score <7 | 100.0 | 7254 | 5.1 | 8 |
| Biselele T et al | 2013 | DRC∗ | Central Africa | cross-sectional | Apgar score <6 | 100.0 | 902 | 4.4 | 7 |
| Mande et al | 2018 | DRC∗ | Central Africa | cross-sectional | Apgar score <7 | 100.0 | 612 | 19.4 | 8 |
| Alemu A. et al | 2019 | Ethiopia | East Africa | cross-sectional | Apgar score <7 | 100.0 | 262 | 32.8 | 7 |
| Abdo RA. et al | 2019 | Ethiopia | East Africa | cross-sectional | Apgar score <7 | 100.0 | 279 | 15.1 | 6 |
DRC∗-Democratic Republic of Congo.
Figure 2Pooled prevalence of perinatal asphyxia in East and Central Africa, 2019 (n = 13).
Figure 3Forest Plot for pooled prevalence of perinatal asphyxia with prediction interval (n = 13).
Subgroup analysis of prevalence of perinatal asphyxia in East and Central Africa.
| Variables | Characterstics | Estimates (95%CI) | I2 tests with p-value |
|---|---|---|---|
| Region | East Africa | 18.0 % (11.4, 26.7%) | I2 = 96.0, p = 0.000 |
| Central Africa | 9.14 % (2.0, 16.2%) | I2 = 90.8, P = 0.000 | |
| Measuring scale | Apgar score <7 | 17.4 % (11.3, 23.5%) | I2 = 96.0, P = 0.000 |
| Apgar score <6 | 8.2 % (0.3, 16.1%) | I2 = 86.9, p = 0.006 |
Related factors with heterogeneity of perinatal asphyxia prevalence in the current meta-analysis.
| Variables | Coefficient | P-value |
|---|---|---|
| Publication years | 2.9 (0.6, 4.8) | 0.8 |
| Sample size | -0.1 (-1.5, 0.6) | 0.4 |
| Response rate | -9.5 (-14.5, -0.7) | 0.4 |
Figure 4Funnel plot for publication bias, logprop or lnp (log of proportion) represented in the X-Axis and standard error of log proportion in the Y-Axis.
Figure 5The trim fill analysis showed the pooled prevalence when the unpublished studies are filled.
Figure 6The sensitivity analysis showed the pooled prevalence when the studies omitted step by step.
The sensitivity analysis to estimate of the prevalence of perinatal asphyxia in East and Central African countries.
| Study omitted | Prevalence (95%CI) |
|---|---|
| Sepeku A et al, 2011 | 15.5 (10.3, 20.7) |
| Belachew et al, 2017 | 16.2 (10.8, 21.7) |
| Ibrahim A et al, 2017 | 17.1 (11.6, 22.5) |
| Kibai K et al, 2017 | 14.8 (9.8, 19.8) |
| Demisse G et al, 2017 | 16.2 (10.8, 21.7) |
| Gebreheat G et al, 2018 | 15.4 (10.2, 20.6) |
| Asfere W et al, 2018 | 14.8 (9.8, 19.7) |
| Gichogo M et al, 2018 | 16.9 (11.3, 22.5) |
| Biselele T et al, 2013 | 16.9 (11.4, 22.6) |
| Mande et al, 2018 | 15.6 (10.6, 20.9) |
| Abkika BM et al, 2018 | 16.9 (11.3, 22.5) |
| Alemu A. et al, 2019 | 14.5 (9.7, 19.3) |
| Abdo RA. et al, 2019 | 16.0 (10.6, 21.4) |
| Search # | Query | Items found |
|---|---|---|
| #1 | perinatal | 119521 |
| #2 | (birth) OR parturition | 527962 |
| #3 | (newborn) OR neonate | 249893 |
| #4 | (asphyxia) OR (suffocation) OR respiratory distress syndrome | 88236 |
| #5 | Search (Tanzania AND Burundi AND Rwanda AND Uganda AND Sudan AND Ethiopia AND Eritrea AND Djibouti AND Somalia AND Kenya AND Angola AND Cameroon AND Central African Republic AND Chad AND Democratic Republic of the Congo AND Equatorial Guinea AND Gabon AND Republic of the Congo) | 279 |
| #6 | #1 AND #2 AND #3 AND #4 AND #5 | 11 |
| Selection | Comparability | Outcome | Total score | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Study | Quality assessor | Representativeness of sample (∗, ∗) | Sample size (∗) | Non-respondents (∗) | Ascertainment (∗∗) | Study controls for most important factor (∗) | The study control for any additional factor (∗) | Assessment of the outcome (∗) | Statistical test (∗) | |
| Sepeku A et al. | YW | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
| AY | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| EA | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | ||
| WA | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | ||
| Belachew et al. | YW | 1 | 0 | 0 | 2 | 1 | 1 | 1 | 0 | 6 |
| AY | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| EA | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| WA | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | ||
| Ibrahim A et al. | YW | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 6 |
| AY | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | ||
| EA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| WA | 1 | 0 | 1 | 2 | 1 | 0 | 0 | 1 | ||
| Kibai K et al. | YW | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
| AY | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| EA | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||
| WA | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | ||
| Demisse G et al. | YW | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
| AY | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| EA | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | ||
| WA | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Gebreheat G et al. | YW | 2 | 0 | 1 | 2 | 1 | 1 | 1 | 0 | 8 |
| AY | 2 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | ||
| EA | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| WA | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | ||
| Asfere W et al. | YW | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
| AY | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| EA | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | ||
| WA | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | ||
| Gichogo M et al. | YW | 2 | 0 | 0 | 2 | 1 | 1 | 1 | 0 | 8 |
| AY | 2 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | ||
| EA | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| WA | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||
| Abkika BM et al. | YW | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 8 |
| AY | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| EA | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||
| WA | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 1 | ||
| Biselele T et al. | YW | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
| AY | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| EA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| WA | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | ||
| Mande et al. | YW | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 8 |
| AY | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| EA | 2 | 1 | 1 | 2 | 1 | 1 | 0 | 1 | ||
| WA | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 1 | ||
| Alemu A. et al. | YW | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
| AY | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | ||
| EA | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | ||
| WA | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Abdo RA. et al. | YW | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 6 |
| AY | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | ||
| EA | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | ||
| WA | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| Item | Kappa | SEM | 95% CI |
|---|---|---|---|
| Representativeness of sample | 0.37 | 0.07 | (1.00, 1.30) |
| Sample size | 0.03 | 0.06 | (0.69, 0.91) |
| Non-respondents | 0.16 | 0.05 | (0.77, 0.96) |
| Ascertainment | 0.17 | 0.07 | (1.00, 1.30) |
| Study controls for most important factor | 0.02 | 0.02 | (0.94, 1.02) |
| The study control for any additional factor | 0.01 | 0.06 | (0.65, 0.89) |
| Assessment of the outcome | 0.02 | 0.05 | (0.74, 0.95) |
| Statistical test | 0.16 | 0.06 | (0.56, 0.82) |
| Overall | 0.30 | 0.22 | (0.17, 0.63) |